Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Non-invasive Brain Stimulation for Treating Visual Defects: A Systematic Review and Meta-analysis
P11 - Poster Session 11 (5:30 PM-6:30 PM)

Visual functions are entangled with cortical areas responsible for transcoding the images we see each second. Moreover, cortical integrity is important for visual functions to operate properly. Stroke, optic neuropathy, or glaucoma would result in vision loss or Visual field defect (VFD). In addition, homonymous hemianopia is a commonly observed defect. Recently, one of the commonly used procedures to relieve VFD is non-invasive brain stimulation (NIBS): a superficial stimulator coil that generates an electric current directed to the area of interest.

We evaluated the efficacy of applying repetitive transorbital alternating current stimulation (rTACS) to patients suffering from visual defects, especially homonymous hemianopia.
A comprehensive search covering publications in PubMed, Embase, Cochrane, and Scopus, spanning until September 2023 was performed. Relevant Randomized controlled trials (RCTs) were selected, and their data were extracted and analyzed using the R (V.4.2.2) software. Pooled mean difference (MD) was calculated for change in the high-resolution perimetry detection accuracy (HRP DA) and fixation accuracy (HRP FA), static automated perimetry foveal threshold (SAP FT), and visual acuity (VA) of near vision outcomes.
We included 4 RCTs with a total of 228 patients. Compared to the sham group, rTACS patients had a significantly higher HRP DA (MD= 0.35; 95% CI [0.003,0.694] P=0.048). However, the pooled analysis did not favor any of the compared groups in HRP FA, SAP FT, VA of near vision, and mean threshold (MD=0.14; 95%CI [-0.21,0.48] P=0.43], (MD= 0.17; 95%CI [-0.11,0.45] P=0.23), (MD= 0.32; 95%CI [-0.24,0.88] P=0.26), and (MD= 0.31; 95%CI [-0.04,0.65] P=0.08) respectively.

Current evidence suggests that rTACS exhibits a promising approach in homonymous hemianopia patients, where it significantly increased HRP DA. Despite the results' failure to attain statistical significance in some outcomes, it underscores the necessity for larger RCTs with longer follow-up periods.

Mostafa M. Meshref, MD (Al-Azhar University, Cairo)
Dr. Meshref has nothing to disclose.
Ahmed Abbas No disclosure on file
Heba Aboeldahab No disclosure on file
Amr Hassan No disclosure on file
Amr Elrosasy No disclosure on file
Safia Lorabi (Azur plage Physical Medicine And Rehabilitation center) No disclosure on file
Yousef A. Hawas Mr. Hawas has a non-compensated relationship as a Faculty with American Academy of Neurology Institution (AANI); NeuroBytes: Medical Students Series that is relevant to AAN interests or activities.
Benyameen Mosa No disclosure on file
Ahmed S. Negida, MD, PhD (Virginia Commonwealth University) Dr. Negida has nothing to disclose.